Cargando…
FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
Forkhead box K2 (FOXK2) was first identified as an NFAT-like interleukin-binding factor. FOXK2 has been reported to act as either oncogene or tumor suppressor. However, functional and regulating mechanisms of FOXK2 in epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) remain u...
Autores principales: | Kong, Jian, Zhang, Qingyun, Liang, Xuefeng, Sun, Wenbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706124/ https://www.ncbi.nlm.nih.gov/pubmed/33313412 http://dx.doi.org/10.1515/med-2020-0129 |
Ejemplares similares
-
circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma
por: Chen, Wenqi, et al.
Publicado: (2021) -
Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer
por: Liu, Xi, et al.
Publicado: (2018) -
Regulation and roles of FOXK2 in cancer
por: Kang, Yuanyuan, et al.
Publicado: (2022) -
FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism
por: Sakaguchi, Masaji, et al.
Publicado: (2019) -
Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Zhang, Qingyun, et al.
Publicado: (2017)